Kazuhiro Asami
Sakai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.
Journal: Clinical lung cancer
Published: May 31, 2016
Brain Metastasis of Pleural Mesothelioma after a Subarachnoid Hemorrhage.
Journal: Internal medicine (Tokyo, Japan)
Published: April 05, 2016
Long-term complete response in a patient with disseminated pulmonary pleomorphic carcinoma induced by cisplatin and gemcitabine.
Journal: Internal medicine (Tokyo, Japan)
Published: November 18, 2014
Treatment strategy for activating EGFR-mutated non-small cell lung cancer after failure of first-generation EGFR-TKIs
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: June 12, 2014
Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 21, 2014
A case of large-cell neuroendocrine carcinoma harboring an EML4-ALK rearrangement with resistance to the ALK inhibitor crizotinib.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 16, 2014
A pilot study of cisplatin and etoposide with and without radiotherapy for advanced malignant thymoma.
Journal: Anticancer research
Published: April 03, 2014
Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer.
Journal: Oncology letters
Published: February 13, 2014
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer.
Journal: World journal of clinical oncology
Published: December 22, 2013
Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan.
Journal: Thoracic cancer
Published: November 21, 2013
Early pharmacodynamic assessment using ¹⁸F-fluorodeoxyglucose positron-emission tomography on molecular targeted therapy and cytotoxic chemotherapy for clinical outcome prediction.
Journal: Clinical lung cancer
Published: November 18, 2013
Last Updated: 09/26/2026